Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Mark S Clements"'
Autor:
Andreas A Karlsson, Shuang Hao, Alexandra Jauhiainen, K Miriam Elfström, Lars Egevad, Tobias Nordström, Emelie Heintz, Mark S Clements
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246674 (2021)
ObjectivesThe European Randomized Study of Screening for Prostate Cancer found that prostate-specific antigen (PSA) screening reduced prostate cancer mortality, however the costs and harms from screening may outweigh any mortality reduction. Compared
Externí odkaz:
https://doaj.org/article/595dd50b114243c0aa3c321fc831be59
Autor:
Sara Fogelberg, Mark S Clements, Kine Pedersen, Stephen Sy, Pär Sparén, Jane J Kim, Emily A Burger
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239611 (2020)
BackgroundSweden revised their cervical cancer screening program in 2017 to include cytology-based screening for women aged 23-29 years and primary human papillomavirus (HPV) testing for women aged 30-64 years; however, alternative strategies may be
Externí odkaz:
https://doaj.org/article/f353827e457f4b4ca3c742139a76191f
Autor:
Rosemary J Korda, Dr, PhD, Mark S Clements, PhD, Bruce K Armstrong, Prof, DPhil, Hsei Di Law, MPH, Tenniel Guiver BMath, Philip R Anderson, PhD, Susan M Trevenar, BSc, Martyn D Kirk, PhD
Publikováno v:
The Lancet Public Health, Vol 2, Iss 11, Pp e522-e528 (2017)
Summary: Background: The health risks associated with living in houses insulated with asbestos are unknown. Loose-fill asbestos was used to insulate some houses in the Australian Capital Territory (ACT). We compared the incidence of mesothelioma and
Externí odkaz:
https://doaj.org/article/2ca1387340b84efa8eeb52fb3b8acf76
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171013 (2017)
OBJECTIVE:To develop a method for estimating the future numbers of prostate cancer survivors requiring different levels of care. DESIGN, SETTING AND PARTICIPANTS:Analysis of population-based cancer registry data for prostate cancer cases (aged 18-84
Externí odkaz:
https://doaj.org/article/755860675ead404eb386ebde568a9a3b
Autor:
David P Smith, Marianne F Weber, Kay Soga, Rosemary J Korda, Gabriella Tikellis, Manish I Patel, Mark S Clements, Terry Dwyer, Isabel K Latz, Emily Banks
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e109278 (2014)
BACKGROUND: Despite growing interest in prevention of lower urinary tract symptoms (LUTS) through better understanding of modifiable risk factors, large-scale population-based evidence is limited. OBJECTIVE: To describe risk factors associated with s
Externí odkaz:
https://doaj.org/article/8c22ed8f98d74f02b977a3fa877b4b17
Publikováno v:
BMJ Open, Vol 1, Iss 1 (2011)
Introduction Current strategies for the management of prostate cancer are inadequate in Australia. We will, in this study, estimate current service needs and project the future needs for prostate cancer patients in Australia.Methods and analysis Firs
Externí odkaz:
https://doaj.org/article/af0806a5204c429d830f23aa6f56c021
Autor:
Shuang, Hao, Emelie, Heintz, Ellinor, Östensson, Andrea, Discacciati, Fredrik, Jäderling, Henrik, Grönberg, Martin, Eklund, Tobias, Nordström, Mark S, Clements
Publikováno v:
European Urology. 82:12-19
Stockholm3 is a risk model that combines the prostate-specific antigen (PSA) test, other plasma protein biomarkers, single nucleotide polymorphisms, and clinical variables. The STHLM3-MRI study (NCT03377881) found that the Stockholm3 test with magnet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a0f155a9c8652f037c5f841b97ad22f
https://doi.org/10.1016/j.eururo.2021.12.021
https://doi.org/10.1016/j.eururo.2021.12.021
Autor:
John J. Garber, Paul J. Lochhead, Amiko M. Uchida, Bjorn Roelstraete, David Bergman, Mark S. Clements, Jonas F. Ludvigsson
Publikováno v:
Esophagus. 19:535-541
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b9369f272f7882818b8cfe9df5aa478
https://doi.org/10.1007/s10388-022-00926-5
https://doi.org/10.1007/s10388-022-00926-5
Publikováno v:
JAMA Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ce01604bafe1f4d602b5385af430c68
https://doi.org/10.1001/jamaoncol.2023.0257
https://doi.org/10.1001/jamaoncol.2023.0257
Autor:
Edna Keeney, Sabina Sanghera, Richard M. Martin, Roman Gulati, Fredrik Wiklund, Eleanor I. Walsh, Jenny L. Donovan, Freddie Hamdy, David E. Neal, J. Athene Lane, Emma L. Turner, Howard Thom, Mark S. Clements
Publikováno v:
Keeney, E, Sanghera, S, Martin, R M, Gulati, R, Wiklund, F, Walsh, E I, Donovan, J L, Hamdy, F C, Neal, D, Lane, J A, Turner, E L, Thom, H H Z & Clements, M 2022, ' Cost-effectiveness analysis of prostate cancer screening in the UK : A decision model analysis based on the CAP trial ', PharmacoEconomics, vol. 40, no. 12, pp. 1207-1220 . https://doi.org/10.1007/s40273-022-01191-1
Background and ObjectiveMost guidelines in the UK, Europe and North America do not recommend organised population-wide screening for prostate cancer. Prostate-specific antigen-based screening can reduce prostate cancer-specific mortality, but there a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5307612b592266761082b9ed571bc990
https://hdl.handle.net/1983/b48d291d-4c8f-4710-8952-14da8cefef6e
https://hdl.handle.net/1983/b48d291d-4c8f-4710-8952-14da8cefef6e
